How to Stop HRT Safely: Tapering, Symptom Return and When to Consider Lifelong Use
A guide to stopping HRT in perimenopause and menopause. Covers tapering vs stopping abruptly, symptom return, and when lifelong HRT is worth considering.
Why Stopping HRT Is Not Straightforward
The decision to stop HRT is not one to take lightly or to make without a clear plan. For many women, HRT has become a significant part of managing daily life, and stopping abruptly can trigger a rapid return of symptoms that can feel worse than those they experienced before starting treatment. HRT does not cure the underlying hormonal transition of perimenopause; it manages its effects. When HRT is stopped, the body is once again relying on its own fluctuating or depleted hormone production, and symptoms can return within days or weeks. That said, many women do stop HRT successfully, particularly after completing the menopausal transition, and go on to feel well without it. The key factors are timing, method, and expectation-setting. Stopping HRT during a particularly difficult life period, during illness, or cold turkey after many years without a plan is associated with the worst outcomes. Stopping gradually, at a time when life is relatively stable, and with a clear understanding of what to do if symptoms return makes the process significantly more manageable.
Tapering vs Stopping Abruptly
Most menopause specialists recommend a tapering approach to stopping HRT rather than stopping abruptly, particularly for women who have been on HRT for more than a year or who are on moderate to higher doses. Tapering means gradually reducing the dose over several weeks or months rather than stopping all at once. For gel or spray users, this might mean reducing from two pumps to one pump for six to eight weeks before stopping entirely. For patch users, stepping down from a higher-strength patch to a lower-strength one before stopping. For oral HRT users, reducing to a lower tablet dose before discontinuing. The rationale is that abrupt stopping creates a sharp hormonal withdrawal that the body has not had time to prepare for, while tapering allows a more gradual adjustment. Withdrawal symptoms such as increased hot flashes, sleep disruption, mood changes, and joint stiffness are more common and more severe with abrupt stopping. That said, some women stop abruptly without major difficulty, particularly those who are well past the menopausal transition and whose endogenous hormone production has fully wound down. Individual responses vary considerably.
Symptom Return: What to Expect
Symptom return is the most commonly experienced consequence of stopping HRT and the main reason many women restart. The likelihood and severity of symptom return depend on how long a woman used HRT, her underlying hormonal status, how long she has been post-menopausal, and individual sensitivity. Women who stop HRT in their mid-50s after several years of use may find that symptoms are much milder than they were during active perimenopause, as the transition is now complete and the body has reached a new baseline. Others find that hot flashes, sleep disruption, and mood changes return with considerable intensity. A helpful perspective is that stopping HRT is not a permanent commitment. If symptoms return and significantly impact quality of life, restarting HRT is a valid and recognised option. NICE guidelines do not place a maximum age or duration limit on HRT for women who have an ongoing clinical need. The idea that HRT must be stopped by a certain age or after a set number of years is not supported by current evidence for most healthy women.
Non-HRT Strategies to Support the Transition Off HRT
For women who want to stop HRT and manage the transition without reinstating it, several strategies can reduce the impact of symptom return. Lifestyle foundations matter significantly. Regular exercise, particularly strength training and cardio, helps regulate body temperature, supports mood, improves sleep quality, and maintains bone density. A diet rich in phytoestrogens, found in soy, flaxseed, chickpeas, and lentils, may offer modest symptom relief for some women. Cognitive behavioural therapy (CBT) adapted for menopause has good evidence for reducing the distress associated with hot flashes and improving sleep. SSRIs and SNRIs at low doses can reduce hot flash frequency and are used by some women as a non-hormonal bridge. Clonidine is another option, though less commonly used. Ensuring vitamin D and calcium intake are adequate is particularly important when stopping HRT, as bone protective effects are lost once oestrogen is withdrawn. A DEXA scan to assess bone density before stopping is worth discussing with a GP, especially for women who started HRT young or who have other bone health risk factors.
When to Consider Lifelong HRT
The traditional view that HRT should be taken for the shortest possible time is being increasingly challenged by evolving evidence on its long-term benefits. For some women, continuing HRT beyond the typical five to ten year window is not only appropriate but genuinely beneficial. Women with premature ovarian insufficiency (POI), who entered menopause before age 40 or 45, are advised to continue HRT until at least the natural age of menopause (51 to 52) because of the elevated risks of cardiovascular disease, osteoporosis, and cognitive decline associated with prolonged oestrogen deficiency in younger women. Beyond this group, NICE acknowledges that long-term or lifelong HRT may be appropriate for women with significant ongoing symptoms, women at high fracture risk, or women whose quality of life is substantially impaired without it. The decision to continue HRT beyond five years should involve an annual review with a prescriber, ideally including an updated discussion of breast cancer risk with the specific formulation being used. For women using oestrogen-only HRT (after hysterectomy), long-term use carries no significant increased breast cancer risk, making lifelong use a straightforward option for many.
Having the Conversation With Your GP
Many women feel pressure to stop HRT at an arbitrary milestone, often because a GP or practice nurse suggests it at a routine review without a detailed risk-benefit discussion. It is entirely reasonable to ask for the evidence behind a recommendation to stop, to request a referral to a menopause specialist if you feel the conversation is not nuanced enough, and to seek a second opinion if needed. The British Menopause Society and the Menopause Charity both provide guidance that supports women in advocating for evidence-based care. If you do want to stop HRT, plan the tapering schedule with your prescriber, set a realistic timeline, and agree in advance on a plan if symptoms return. Stopping HRT is not a failure; it is a clinical decision that should be revisited if it proves to be wrong for you at that time. The door to restarting is always open. What matters most is that the decision is made with full information, a clear plan, and ongoing access to support from a clinician who understands the evidence.
Related reading
Get your personalized daily plan
Track symptoms, match workouts to your day type, and build a routine that adapts with you through every phase of perimenopause.